Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Biotechnology
The English High Court has ruled in favour of Fujifilm Kyowa Kirin Biologics in a case against AbbVie, granting Fujifilm an Arrow declaration allowing it to market a biosimilar of AbbVie’s Humira (adalimumab), a medication used to treat arthritis.   6 March 2017
Europe
The English High Court handed down a split decision on patentability in a dispute between Edwards Lifesciences and Boston Scientific over patents covering transcatheter heart valves.   6 March 2017
Americas
Drugs company Purdue Pharma has filed a complaint against US-based generics company Amneal Pharmaceuticals for alleged patent infringement.   3 March 2017
Americas
Otsuka Pharmaceutical has agreed to acquire Neurovance, a privately held clinical stage pharma company.   3 March 2017
Americas
The US Court of Appeals for the Federal Circuit has partially affirmed a ruling by a district court in a patent dispute between Bayer and Dow Agrosciences.   2 March 2017
Americas
A US court has granted Pfizer a temporary restraining order against a former employee for allegedly stealing trade secrets.   2 March 2017
Americas
Speciality pharmaceutical company Orexo has filed a complaint against Actavis and its parent company Teva for infringing patents protecting Orexo’s Suboxone and Subutex.   1 March 2017
Americas
The US Court of Appeals for the Federal Circuit has remanded a decision to the Patent Trial and Appeal Board concerning a dispute between LA Biomedical Research Institute and Eli Lilly.   1 March 2017
Big Pharma
The World Health Organization has published a list of antibiotic-resistant “priority pathogens”, a catalogue of 12 families of bacteria which it claims pose the greatest threat to human health.   28 February 2017
Americas
The US Court of Appeals for the Federal Circuit erred in holding that biosimilar applicants must give 180 days’ pre-marketing notice after an application has been approved by the US Food and Drug Administration, according to the acting solicitor general.   28 February 2017